The world’s largest 1,000 public corporate R&D spenders recently hit a record high of US$638 billion ensuring life-changing innovation at every turn. Or does it?
The latest edition of the Global Innovation 1000 study from Booz & Company argues that it ‘how the money is spent’ is much more important than ‘how much’. To back up the claim, it released a list of the world’s top 10 R&D spenders as well as a list of the world’s 10 most innovative companies.
There wasn’t much overlap.
Volkswagen of Germany tops the money list at $11.4 billion, followed by (in order): Samsung (South Korea—$10.4B), Roche (Switzerland—$10.2B), Intel (U.S.—$10.1B), Microsoft (U.S.—$9.8B), Toyota (Japan—$9.8B), Novartis (Switzerland—$9.3B), Merck (U.S.—$8.2B), Pfizer (U.S.—$7.9B) and Johnson & Johnson (U.S.—$7.7B).
Contrast that list with the most innovative companies where, coincidentally, all but one are from the U.S. Apple comes out on top for the fourth straight year, followed by (in order): Google, Samsung, Amazon, 3M, General Electric, Microsoft, IBM, Tesla Motors and Facebook.
The only two to make it on both lists are Samsung (from South Korea) and Microsoft.
Other key findings from this year's Global Innovation 1000 study:
A Look Back at Innovation Daily
The Long Road to Crowdfunding